Tempest Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Tempest Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.42 | $-0.40 | -5.00 % |
Mar 2024 | 2024-05-09 | $-0.36 | $-0.39 | 7.69 % |
Dec 2023 | 2024-03-19 | $-0.34 | $-0.39 | 12.8 % |
Sep 2023 | 2023-11-08 | $-0.48 | $-0.57 | 15.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Tempest Therapeutics (TPST) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.42, which missed the estimate of $-0.40.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.